                </a></li></ul></div><p><strong>Figure 2. </strong></p><a id="article1.body1.sec2.sec1.fig2.caption1.p1" name="article1.body1.sec2.sec1.fig2.caption1.p1"></a><p>Immunohistological analysis of dormant tumors in PPARα KO mice. The dormant tumors contain viable and proliferating cells, and show decreased microvessel (PECAM1) and increased leukocyte (CD45) staining. (A) Dormant PPARα(−/−)MEF/RS tumors in PPARα KO mice from day 60 post-tumor implantation revealed abundant SV40 large T-antigen staining and proliferation (Ki-67). Dormant PPARα(−/−)MEF/RS tumors on day 60 were implanted as pieces (1 mm<sup>3</sup>) into PPARα WT and KO mice (3 mice in each group). (B) Immunohistochemical analysis of subcutaneous B16-F10/GFP tumors (H&amp;E, CD45/brown color, PECAM-1/brown color) from day 30 post-implantation in PPARα WT mice and KO mice. Scale bars, 100 µm.</p>
